Mild COVID-19 patients exhibit more CD8+ CTL cells [7,8], while patients with severe disease have predominantly increased SARS-CoV-2-specific CD4+ T cells in their recovery-stage of the disease [7,8]. This evidence concerns the gene CD4 and COVID-19.